Troy Cox

Insider Reports History

Reporting-owner location: Cambridge, MA
Latest reporting-owner signature: /s/ Elimara Brunetto as Attorney-in-Fact for Troy Cox
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Troy Cox

Form 4 holding Director

SOPHiA GENETICS SA

Security class: Ordinary Shares
Shares / value: 309,019
Estimated value: $1,421,487
Report date: 18 Mar 2026
Price: $4.60
Ownership: Direct

Form 4 holding Director

STANDARD BIOTOOLS INC.

Security class: Common Stock
Shares / value: 376,586
Estimated value: $440,605
Report date: 26 Feb 2026
Price: $1.17
Ownership: Direct

Form 4 holding Director

STANDARD BIOTOOLS INC.

Security class: Stock Option (Right to buy)
Shares / value: 125,660
Estimated value: $270,077
Report date: 20 Jun 2025
Price: $3.74
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Zymeworks Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 31,000
Estimated value
Report date: 10 Dec 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Zymeworks Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 9,000
Estimated value
Report date: 06 May 2021
Price
Ownership: Direct
Underlying class: Common Shares
Underlying amount

Form 4 holding Director

SomaLogic, Inc.

Security class: Common Stock
Shares / value: 0
Estimated value
Report date: 05 Jan 2024
Price: $2.43
Ownership: Direct

Form 4 holding Director

SomaLogic, Inc.

Security class: Restricted Stock Unit
Shares / value: 0
Estimated value
Report date: 05 Jan 2024
Price: $2.43
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

SomaLogic, Inc.

Security class: Stock Option (Right to buy)
Shares / value: 0
Estimated value
Report date: 05 Jan 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

SomaLogic, Inc.

Security class: Warrant to purchase common stock (Right to buy)
Shares / value: 0
Estimated value
Report date: 05 Jan 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Troy Cox

3 SOPH

SOPHiA GENETICS SA

Report period: 18 Mar 2026
Transactions: 0
Transaction value: $0
Accepted by SEC: 18 Mar 2026, 09:45
Role: Director
Next action: Open filing details

4 LAB

STANDARD BIOTOOLS INC.

Report period: 26 Feb 2026
Transactions: 1
Transaction value: +$66,999
Accepted by SEC: 02 Mar 2026, 19:32
Role: Director
Next action: Open filing details

4/A LAB

STANDARD BIOTOOLS INC.

Report period: 20 Jun 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 30 Jul 2025, 20:10
Role: Director
Next action: Open filing details

4 LAB

STANDARD BIOTOOLS INC.

Report period: 28 Feb 2025
Transactions: 1
Transaction value: +$66,999
Accepted by SEC: 04 Mar 2025, 17:51
Role: Director
Next action: Open filing details

4 ZYME

Zymeworks Inc.

Report period: 10 Dec 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Dec 2024, 17:52
Role: Director
Next action: Open filing details

4 LAB

STANDARD BIOTOOLS INC.

Report period: 28 Jun 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Jul 2024, 17:19
Role: Director
Next action: Open filing details

4

SomaLogic, Inc.

Report period: 05 Jan 2024
Transactions: 7
Transaction value: $0
Accepted by SEC: 09 Jan 2024, 21:30
Role: Director
Next action: Open filing details

4 LAB

STANDARD BIOTOOLS INC.

Report period: 05 Jan 2024
Transactions: 8
Transaction value: $0
Accepted by SEC: 09 Jan 2024, 18:05
Role: Director
Next action: Open filing details

3 LAB

STANDARD BIOTOOLS INC.

Report period: 05 Jan 2024
Transactions: 0
Transaction value: $0
Accepted by SEC: 09 Jan 2024, 18:03
Role: Director
Next action: Open filing details

4 ZYME

Zymeworks Inc.

Report period: 07 Dec 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 08 Dec 2023, 17:26
Role: Director
Next action: Open filing details

4

SomaLogic, Inc.

Report period: 17 Mar 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 22 Mar 2023, 06:02
Role: Executive Chair, Director
Next action: Open filing details

4 ZYME

Zymeworks Inc.

Report period: 21 Dec 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 23 Dec 2022, 18:00
Role: Director
Next action: Open filing details

4

SomaLogic, Inc.

Report period: 17 Oct 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 18 Oct 2022, 17:52
Role: Executive Chair, Director
Next action: Open filing details

4

SomaLogic, Inc.

Report period: 01 Mar 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 03 Mar 2022, 20:07
Role: Director
Next action: Open filing details

4

SomaLogic, Inc.

Report period: 27 Oct 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Dec 2021, 15:55
Role: Director
Next action: Open filing details

4

SomaLogic, Inc.

Report period: 01 Sep 2021
Transactions: 4
Transaction value: +$500,000
Accepted by SEC: 03 Sep 2021, 20:30
Role: Director
Next action: Open filing details

4

Zymeworks Inc.

Report period: 06 May 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 07 May 2021, 20:45
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .